iBio (IBIO) Income from Continuing Operations (2010 - 2026)

iBio (IBIO) has 17 years of Income from Continuing Operations data on file, last reported at 7849000.0 in Q1 2026.

• On a quarterly basis, Income from Continuing Operations fell 58.63% year-over-year to 7849000.0 in Q1 2026; TTM through Mar 2026 was 27754000.0, a 70.37% decrease from a year earlier, with the FY2025 full-year figure at 81557000.0, down 14.67% from the prior year.
• Income from Continuing Operations for Q1 2026 stood at 7849000.0, up from 9093000.0 in the prior quarter.
• Over the last five years, Income from Continuing Operations for IBIO reached as high as 2635000.0 in Q1 2024 and fell as low as 10563000.0 in Q4 2022.
• Historically, Income from Continuing Operations has averaged 6040294.12 across 5 years, with a median of 5092000.0 in 2025.
• Across the five-year window, Income from Continuing Operations soared 79.75% in 2022 and tumbled 104.43% in 2025, its largest moves.
• Year by year, Income from Continuing Operations stood at 10563000.0 in 2022, then jumped by 57.51% to 4488000.0 in 2023, then grew by 0.89% to 4448000.0 in 2024, then tumbled by 104.43% to 9093000.0 in 2025, then climbed by 13.68% to 7849000.0 in 2026.
• Per Business Quant data, the three most recent Income from Continuing Operations figures were 7849000.0 in Q1 2026, 9093000.0 in Q4 2025, and 5720000.0 in Q3 2025.